Senate Stands Firm Against Proposed Cuts
US Senate Opposes Trump's Massive Budget Cuts to Science Agencies
The US Senate Appropriations Committee has rejected President Trump's proposed drastic budget cuts to key scientific bodies, including the NSF and NASA. The proposed plan raised alarms as it called for a 57% reduction in the NSF budget, labeling it 'woke,' and aimed to nearly halve NASA's science funding. The Senate's pushback hints at potential bipartisan support for preserving science funding despite presidential opposition.
Introduction
Trump's Proposed Budget Cuts
Impact on NSF and NASA
Congressional Response
Public and Expert Reactions
Economic and Social Implications
Political Dynamics and Future Concerns
Conclusion
Related News
Apr 14, 2026
EPA's Chemical Panel Candidate List Features Controversial Return of Industry Ties
The EPA is shaking things up by seeking candidates for its Science Advisory Committee on Chemicals, crucial for guiding chemical risk evaluations. Among the 29 candidates is Michael Dourson, a figure from Trump's era known for minimizing chemical risks, alongside experts from Tesla and NASA. This selection raises eyebrows about the impacts of industry influence on public health policies.
Apr 13, 2026
Elon Musk and Jeff Bezos Intensify Space Race for Lunar Dominance
Elon Musk's SpaceX and Jeff Bezos's Blue Origin are in a fierce competition to land humans on the Moon, with NASA's Artemis program as the battleground. SpaceX leads with its Starship lunar lander, while Blue Origin fights back with its Blue Moon project despite earlier legal battles. The stakes are high as both companies vie for contracts and national prestige, in a modern-day "space race."
Apr 12, 2026
SpaceX IPO Speculation Soars! A Journey Through Risks, Rewards, and Rockets
SpaceX is stirring up Wall Street with talks of a massive IPO, sparking debates among investors over its astronomical valuations and CEO Elon Musk's ambitious plans. As fanfare grows for a potential public offering in 2026-2027, concerns about burn rates, regulatory issues, and Musk's leadership cast shadows. With a market value already soaring to $350 billion, all eyes are on SpaceX's rocket trajectory – both to Mars and the stock market.